NXT logo

NXT

Nextracker Inc.

$115.60
-$1.49(-1.27%)
72
Overall
70
Value
83
Tech
63
Quality
Market Cap
$15.53B
Volume
2.03M
52W Range
$36.06 - $131.59
Target Price
$109.85

Company Overview

Mkt Cap$15.53BPrice$115.60
Volume2.03MChange-1.27%
P/E Ratio30.5Open$115.00
Revenue$3.0BPrev Close$117.09
Net Income$509.2M52W Range$36.06 - $131.59
Div YieldN/ATarget$109.85
Overall72Value70
Quality63Technical83

No chart data available

About Nextracker Inc.

Nextracker Inc., an energy solutions company, provides solar tracker and software solutions for utility-scale and distributed generation solar projects in the United States and internationally. The company offers tracking solutions, which includes NX Horizon, a solar tracking solution; and NX Horizon-XTR, a terrain-following tracker designed to expand the addressable market for trackers on sites with sloped, uneven, and challenging terrain. It also provides TrueCapture, a self-adjusting tracker control system, which boosts solar power plant production by optimizing the position of individual tracker row in response to site features, such as varying topography and changing weather conditions; and NX Navigator, that assists solar power plant owners and operators in monitoring, controlling, and protecting their solar projects. The company was founded in 2013 and is headquartered in Fremont, California. As of March 31, 2024 Nextracker Inc. was formerly a subsidiary of Flex Ltd.

Latest News

Next plc Confirms Total Voting Rights and Share Capital Structure

Next plc ( ($GB:NXT) ) has provided an announcement. Next plc has confirmed that, as of 30 January 2026, its registered share capital comprises 122...

TipRanks UK Auto-Generated Newsdeska day ago

UBS Sticks to Their Buy Rating for Next plc (NXT)

TipRanks Auto-Generated Intelligence Newsdesk7 days ago

BioNxt Moves to Retire $2.7 Million in Debenture Debt via Share Issuance

TipRanks Canadian Auto-Generated Newsdesk11 days ago

BioNxt’s Sublingual Cladribine Film Delivers 40% Higher Exposure in Preclinical MS Study

TipRanks Canadian Auto-Generated Newsdesk13 days ago

BioNxt’s Cladribine Film Shows Superior Bioavailability in Preclinical MS Study

TipRanks Canadian Auto-Generated Newsdesk14 days ago
ABCD
1SymbolPriceChangeVol
2NXT$115.60-1.3%2.03M
3
4
5
6

Get Nextracker Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.